Sai Life Sciences works with innovator pharma and biotech companies to accelerate the discovery, development and manufacture of complex small molecules. Our Vision is to support our global innovator partners bring 25 new medicines to life by 2025.
Employees: 1001-5000
Founded date: 1999
Investors 2
| Date | Name | Website |
| - | HBM Partne... | hbmpartner... |
| - | TPG | tpg.com |
Mentions in press and media 17
| Date | Title | Description |
| 27.08.2025 | TPG Exits Sai Life Sciences with INR 2,675 Cr Stake Sale This exit comes just months after TPG sold a 10 percent stake in Sai Life Sciences for INR 1,505 crore in June this year. | Private equity firm TPG has exited its investment in Sai Life Sciences after selling its entire 14.7 percent stake in the pharmaceutical company. The stake was valued at about INR 2,675 crore and was offloaded through open market transactio... |
| 20.08.2025 | Sai Life Sciences secures SBTi validation for near-term climate targets | - |
| 06.12.2024 | Sai Life Sciences Announces IPO: Bids Set to Open on December 11 Sai Life Sciences, a contract research, development, and manufacturing organization (CRDMO), announced on Friday its plans for the INR ... | Sai Life Sciences, a contract research, development, and manufacturing organization (CRDMO), announced on Friday its plans for its INR 3,043 crore initial public offering (IPO) which is set to open for subscription on December 11. The pharm... |
| 25.07.2024 | Central Bank of India Soars with Record Profits Amidst Market Shifts** ** | ** The Central Bank of India (CBoI) has emerged as a phoenix from the ashes, reporting a staggering 110% increase in net profit for the first quarter of FY25. The bank's net profit reached ₹880 crore, a significant leap from ₹418 crore in t... |
| 19.07.2024 | Northern Arc and Sai Life Look To Raise Funds Through IPO: Secures SEBI Green Light Non-banking credit provider Northern Arc Capital and pharma company Sai Life Sciences, both have filed their respect... | Non-banking credit provider Northern Arc Capital and pharma company Sai Life Sciences, both have filed their respective draft papers with the Indian market regulator Securities and Exchange Board of India (SEBI) for a fundraising of a combi... |
| 22.11.2022 | Stephen Hermitage joins Sai Life Sciences as VP, CMC | MANCHESTER, England and HYDERABAD, India, Nov. 22, 2022 /PRNewswire/ -- Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organisation (CRO-CDMO), today announced the joining of Stephen Hermitage (Steve)... |
| 19.01.2022 | Accomplished Pharma R&D leader, Sauri Gudlavalleti joins Sai Life Sciences as Chief Operating Officer | HYDERABAD, India, Jan. 19, 2022 /PRNewswire/ -- Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO-CDMO), today announced the appointment of Sauri Gudlavalleti as its Chief Operating Off... |
| 20.12.2021 | 2021 Sustainability Report of Sai Life Sciences highlights the momentum gained in its Sustainability choices | Report developed as per Global Reporting Initiative (GRI) standards Extensively deals with the company's response to the Covid-19 pandemic HYDERABAD, India, Dec. 20, 2021 /PRNewswire/ -- Sai Life Sciences, a leading global Contract Research... |
| 01.12.2021 | Sai Life Sciences' pharmaceutical API manufacturing site receives Certificate of Inspection from PMDA, Japan | HYDERABAD, India, Dec. 1, 2021 /PRNewswire/ -- Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO/ CDMO), today announced that the Japanese regulatory agency, Pharmaceuticals and Medical... |
| 11.10.2021 | Sai Life Sciences presents mid-term report on Sai Nxt initiative; reveals upsurge in capabilities | - Completes two-thirds of its investment target of US$150M - Demonstrates a leap forward in capabilities across all focus areas – People, Processes, and Infrastructure HYDERABAD, India, Oct. 11, 2021 /PRNewswire/ -- Sai Life Sciences, a lea... |
Show more